Corcept Therapeutics
CORT
#2406
Rank
A$11.24 B
Marketcap
A$102.73
Share price
-5.10%
Change (1 day)
-10.66%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): A$0.15 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.96 Billion. In 2025 the company made an earning of A$66.48 Million a decrease over its 2024 earnings that were of A$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.15 B140.57%
2025 A$66.48 M-67.29%
2024 A$0.20 B27.66%
2023 A$0.15 B-4.75%
2022 A$0.16 B-9.51%
2021 A$0.18 B-2.91%
2020 A$0.19 B14.87%
2019 A$0.16 B24.71%
2018 A$0.13 B69.32%
2017 A$78.44 M419.26%
2016 A$15.1 M-395.64%
2015 -A$5.11 Million-87.53%
2014 -A$41 Million-33.44%
2013 -A$61.59 Million
2011 -A$47.99 Million17.84%
2010 -A$40.73 Million35.5%
2009 -A$30.06 Million2.84%
2008 -A$29.23 Million60.81%
2007 -A$18.18 Million-52.14%
2006 -A$37.97 Million20.91%
2005 -A$31.41 Million31.87%
2004 -A$23.82 Million60.54%
2003 -A$14.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.78 B 16,779.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.76 B 11,299.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$10.34 B 6,182.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$51.60 B 31,249.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$9.97 B 5,961.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.81 B 10,117.29%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$72.21 Million-143.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B-28.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$64.8 M-60.63%๐Ÿ‡บ๐Ÿ‡ธ USA